Search


Ireland's HPRA Guidance: GDP Quality Systems, GXP Regulatory Advice, and Active Substance Registration Changes
The Health Products Regulatory Authority (HPRA) has released updated guidance documents to strengthen pharmaceutical quality systems, regulatory compliance, and operational oversight across Ireland’s healthcare sector. The updated guidance documents include: Guide to Quality System for General Sale Wholesale Distributors Guide to Pre-submission Scientific and Regulatory Advice for GXP Activities Guide to Managing Changes to Registrations of Active Substance Manufacturers, Imp

Sharan Murugan
8 hours ago3 min read
